Injection of autologous volar fibroblasts to the stump site to allow pressure adaptation and enhanced prosthetic use in amputees

Ended Cooperative Agreement Awarded Last action

Award ID
UG3AR079376
Recipient
Awarding agency
Obligated
$1,596,564

Award facts

Completion date
Funding
  • $1,064,376.00 Federal
  • $532,188.00 Non-federal
Funding agency
Office of the Director National Institutes of Health, Department of Health and Human Services
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Description

Abstract
Abstract the long term objective of the proposed research is to use cellular therapy to advance regenerative medicine. In particular, we wish to help amputees who have lost a limb. While major improvements have been made to prosthetics, the skin side of the interface at the stump site was not evolved to bear weight. The stump does not normally have the pressure adaptive abilities of the soles of the foot for example. The present grant proposes to biopsy, purify and expand fibroblasts from an existing palm or sole and inject them into the stump site of an amputee to improve their use of prosthetics. We also propose to study the basic biology behind cell therapy to understand how the injected cells change the native cells, and in turn how those native cells affect the injected cells. The results of this grant will hopefully lead to a new therapy to help not only amputees, but potentially prevent pressure ulcers and provide a platform for future cell therapies.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $532,188 $0
Original award $532,188 $532,188

Quick answers

Who received award UG3AR079376?

UG3AR079376 was awarded to The Johns Hopkins University by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 22, 2021.

How much is award UG3AR079376 worth?

$1,596,564 has been obligated on UG3AR079376: $1,064,376 in federal funding and $532,188 in non-federal funding.

Which agency awarded UG3AR079376?

National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) awarded UG3AR079376, with funding from Office of the Director (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award